stoxline Quote Chart Rank Option Currency Glossary
  
Titan Medical Inc. (TMDI)
0.14  0 (0%)    03-09 16:00
Open: 0.14
High: 0.15
Volume: 7,711,949
  
Pre. Close: 0.14
Low: 0.135
Market Cap: 16(M)
Technical analysis
2023-05-19 4:50:40 PM
Short term     
Mid term     
Targets 6-month :  0.18 1-year :  0.23
Resists First :  0.16 Second :  0.19
Pivot price 0.15
Supports First :  0.1 Second :  0.08
MAs MA(5) :  0.14 MA(20) :  0.14
MA(100) :  0.41 MA(250) :  0.46
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  27.1 D(3) :  33.9
RSI RSI(14): 43.7
52-week High :  1.2 Low :  0.09
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TMDI ] has closed above bottom band by 22.7%. Bollinger Bands are 80.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 46 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.15 - 0.15 0.15 - 0.15
Low: 0.12 - 0.12 0.12 - 0.12
Close: 0.14 - 0.14 0.14 - 0.14
Company Description

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Headline News

Sun, 03 Mar 2024
Titan Medical Inc (NASDAQ:TMDI) Rising From The Dead After Robotic Surgery Breakthrough - Insider Financial

Thu, 09 Mar 2023
Nasdaq delists Titan Medical amid mass layoffs, failed sale - Fierce Biotech

Thu, 12 Jan 2023
Titan Medical shows off Enos surgical robot's next-gen design - Medical Design & Outsourcing

Thu, 12 Jan 2023
Titan Medical meets with strategic buyers and investors as surgical robot developer considers its future - Mass Device

Thu, 10 Nov 2022
Titan Medical to seek share consolidation to keep Nasdaq listing - Mass Device

Sun, 05 Dec 2021
Titan Medical Stock: We're On Sidelines (NASDAQ:TMDI) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 112 (M)
Shares Float 112 (M)
Held by Insiders 0 (%)
Held by Institutions 4.5 (%)
Shares Short 52 (K)
Shares Short P.Month 253 (K)
Stock Financials
EPS -0.16
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.05
Profit Margin -210.5 %
Operating Margin -378.7 %
Return on Assets (ttm) -69.5 %
Return on Equity (ttm) -129.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0.17
Sales Per Share 0.08
EBITDA (p.s.) -0.34
Qtrly Earnings Growth 0 %
Operating Cash Flow -32 (M)
Levered Free Cash Flow -33 (M)
Stock Valuations
PE Ratio -0.87
PEG Ratio 0
Price to Book value 2.31
Price to Sales 1.55
Price to Cash Flow -0.49
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-06-18
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android